OXIGENE, INC. SC 13G

Company

Oncotelic Therapeutics, Inc.

Filed

June 18, 2003

Accession Number

0000902664-03-000839

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →